ArticlePLoS neglected tropical diseases2026
First use of rapid ICT screening for Toxoplasma in pregnant women in Ethiopia: A multicenter study in Bahir Dar, Ethiopia.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundToxoplasma gondii primary infection during pregnancy can lead to congenital transmission and cause serious fetal and neonatal complications. Seroprevalence for toxoplasmosis is an indicator of the intensity of transmission and of the risk of infection during pregnancy, yet such data are limited in Ethiopia. This multi-center study utilizing the immunochromatographic test (Toxoplasma ICT IgG-IgM, LD Bio) aimed at determining the seroprevalence of toxoplasmosis among pregnant women and its associated risk factors in Bahir Dar, Ethiopia.
methodsA cross-sectional study was conducted at two tertiary hospitals. Pregnant women below 20 weeks of gestation were included during the first antenatal care consultation. Participants were selected using systematic random sampling. A blood sample was collected for Toxoplasma serology, and socio-demographic and clinical data were collected through a questionnaire. Serology was performed using a rapid immunochromatographic test (ICT Toxo IgG/IgM, LD Bio). The test detects any Toxoplasma antibody (recent or chronic infection), but not separately reported. Data were analysed using SPSS version 23. Individual data were compared between Toxoplasma-seropositive and seronegative women to determine risk factors for infection. Bivariable and multivariable binary logistic regression were performed to identify factors associated with seropositivity.
resultsOverall, 1010 women were included in the study at their first antenatal care visit (13.89 ± 4.26 weeks of gestation). Their mean age was 26.8 ± 4.67 years, 85.2% resided in urban areas, and the median monthly income was 5000 Ethiopian Birr. The seroprevalence was 75.8%. Seroprevalence increased with age and parity (p < 0.001), but did not differ according to socio-economic parameters, including educational level, monthly income, occupation, residence, or any hygienic factors. Multivariable analysis showed that age (AOR = 1.09), Parity (AOR = 1.33), eating undercooked meat (AOR = 1.29), and consumption of raw milk (AOR = 1.82) were significantly associated with the seropositivity of T. plasma gondii among pregnant women.
conclusionThe burden of toxoplasmosis among pregnant women was high in Bahir Dar. Therefore, efforts should be made to increase women's awareness of risk factors, particularly the habit of consuming raw meat and raw milk. The ease of use of the Toxoplasma ICT test allows serologic screening of pregnant women at antenatal care facilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.